Tags: Drug.

CX157 (proposed trade name TriRima formerly Tyrima) is a selective and reversible inhibitor of MAO-A (RIMA). As of 2007 it was in phase II clinical trials for the treatment of depression.

Loading...

This page contains content from the copyrighted Wikipedia article "CX157"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.